…
Leveljump Healthcare Corp., together with its subsidiaries, provides radiology services. The company offers direct patient images and teleradiology services; in-patient diagnostic imaging facilities, including x-rays, ultrasounds, and mammography; and other medical services. It serves hospitals and clinics. Leveljump Healthcare Corp. is headquartered in Toronto, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Leveljump Healthcare Corp (JUMP.V) is limited; the company is listed on the TSX Venture Exchange and identifies as a healthcare-focused firm. Potential long-term growth drivers include product development, regulatory approvals and market expansion, which may attract investors seeking early-stage healthcare exposure.
Key investment risks include limited disclosure, low liquidity, funding and execution risk, and regulatory and clinical-development uncertainty typical of early-stage healthcare companies.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 |
| Income before tax | -1.03M | -2.44M | 0.23M | -2.23M | -0.13M |
| Net income | 1.16M | -2.21M | 0.23M | -2.23M | -0.13M |
| Selling general administrative | 3.03M | 2.97M | 3.06M | 3.52M | 0.13M |
| Gross profit | 3.19M | 2.36M | 2.49M | 1.35M | 1.04M |
| Reconciled depreciation | 1.50M | 0.60M | 0.21M | 0.03M | 0.03M |
| Ebit | - | - | - | -2.20M | -2.15M |
| Ebitda | - | - | 0.59M | -2.16M | -0.13M |
| Operating income | -0.04M | -0.79M | -0.78M | -2.20M | -0.13M |
| Interest expense | 1.07M | 0.40M | 0.14M | 0.04M | 0.08M |
| Tax provision | -2.19M | -0.24M | - | - | - |
| Net interest income | -1.10M | -0.44M | -0.14M | -0.04M | -0.08M |
| Total revenue | 17.73M | 12.58M | 9.23M | 6.72M | 5.46M |
| Total operating expenses | 17.77M | 13.37M | 10.00M | 8.92M | 0.13M |
| Cost of revenue | 14.54M | 10.23M | 6.74M | 5.37M | 4.41M |
| Total other income expense net | 0.11M | -1.22M | 1.15M | 0.01M | -11.45M |
| Net income from continuing ops | 1.16M | -2.21M | 0.23M | -2.23M | -0.13M |
| Net income applicable to common shares | - | - | - | -2.23M | -11.56M |
| Breakdown | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 |
| Total assets | 21.23M | 19.54M | 13.26M | 4.10M | 0.24M |
| Intangible assets | 6.16M | 6.09M | 6.07M | - | - |
| Total liab | 14.86M | 14.60M | 6.99M | 2.12M | 0.04M |
| Total stockholder equity | 6.36M | 4.94M | 6.27M | 1.98M | 0.20M |
| Other current liab | - | - | - | - | 0.34M |
| Common stock | - | - | - | 12.88M | 10.98M |
| Capital stock | 16.34M | 16.22M | 15.62M | 12.88M | 10.98M |
| Retained earnings | -15.53M | -16.69M | -14.41M | -14.64M | -12.41M |
| Other liab | - | - | - | 0.22M | 0.12M |
| Good will | 3.73M | 3.73M | - | - | - |
| Cash | 0.05M | 0.07M | 0.08M | 0.76M | 0.91M |
| Total current liabilities | 6.47M | 4.27M | 2.96M | 1.90M | 1.43M |
| Net debt | 7.42M | 7.67M | 3.83M | - | - |
| Short long term debt | 1.58M | 0.92M | 0.51M | - | - |
| Property plant equipment | - | - | - | 0.04M | 0.05M |
| Total current assets | 3.22M | 2.33M | 3.37M | 3.95M | 1.92M |
| Long term investments | 0.00M | 0.99M | 2.52M | 0.10M | - |
| Net tangible assets | - | - | - | 1.98M | 0.33M |
| Short term investments | - | - | - | 1.33M | - |
| Net receivables | 1.40M | 1.36M | 1.36M | 1.44M | 0.65M |
| Long term debt | 5.89M | 6.82M | 3.39M | - | 0.06M |
| Accounts payable | 3.44M | 2.53M | 1.27M | 1.87M | 0.92M |
| Non currrent assets other | -0.00M | - | - | - | - |
| Non current assets total | 18.00M | 17.21M | 9.89M | 0.15M | 0.05M |
| Capital lease obligations | 1.48M | 1.98M | 0.27M | 0.03M | 0.06M |
| Breakdown | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 |
| Investments | 1.09M | 0.33M | -5.82M | -0.03M | 0.14M |
| Change to liabilities | - | - | - | -0.04M | -0.17M |
| Total cashflows from investing activities | - | - | - | -0.03M | 0.35M |
| Net borrowings | -0.89M | 3.17M | - | 0.06M | 0.10M |
| Total cash from financing activities | -0.89M | 4.89M | 5.46M | 1.64M | 3.54M |
| Change to operating activities | - | - | - | -0.13M | -0.44M |
| Net income | 1.16M | -2.21M | 0.23M | -2.23M | -11.56M |
| Change in cash | -0.02M | -0.01M | -0.67M | -0.15M | 0.91M |
| Begin period cash flow | 0.07M | 0.08M | 0.76M | 0.91M | 0.12M |
| End period cash flow | 0.05M | 0.07M | 0.08M | 0.76M | 0.22M |
| Total cash from operating activities | 1.68M | 0.66M | -0.31M | -1.77M | -2.99M |
| Issuance of capital stock | 0.00M | 1.72M | 2.52M | 1.60M | 0.23M |
| Depreciation | 1.50M | 0.60M | 0.21M | 0.03M | 0.03M |
| Change to account receivables | -0.04M | 0.17M | -0.48M | -0.17M | -0.03M |
| Other cashflows from financing activities | - | - | - | -0.05M | -0.00M |
| Change to netincome | - | - | - | 0.77M | 9.19M |
| Capital expenditures | 1.02M | 1.73M | 1.65M | 0.03M | 0.00M |
| Change in working capital | 0.73M | 1.16M | -0.03M | -0.34M | -0.00M |
| Stock based compensation | 0.15M | 0.00M | 0.29M | 0.74M | 0.04M |
| Other non cash items | 1.01M | 0.40M | -1.02M | 0.01M | 9.12M |
| Free cash flow | 0.66M | -1.07M | -1.96M | -1.79M | -0.09M |
Sector: Healthcare Industry: Diagnostics & Research
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AVCR Avricore Health Inc |
- -% |
0.05 | - | - | 3.16 | 5.09 | 3.30 | 41.13 |
| TELO Telo Genomics Corp |
- -% |
0.05 | - | - | - | 8.78 | - | -6.32 |
| ARC Arian Resources Corp. |
- -% |
0.01 | - | - | 2.12 | - | 15.59 | 2.25 |
| MBI-H Med BioGene Inc |
-0.01 25.00% |
0.01 | - | - | - | - | - | -3.03 |
Leveljump Healthcare Corp., together with its subsidiaries, provides radiology services. The company offers direct patient images and teleradiology services; in-patient diagnostic imaging facilities, including x-rays, ultrasounds, and mammography; and other medical services. It serves hospitals and clinics. Leveljump Healthcare Corp. is headquartered in Toronto, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Mitchell Geisler | Pres, CEO & Chairman | 1970 |
| Mr. Robert Landau | CFO, Corp. Sec. & Director | 1971 |
| Mr. Mitchell Geisler | President, CEO & Chairman of the Board | 1970 |
| Mr. Robert G. Landau | CFO, Corporate Secretary & Director | 1971 |
| Mr. Mitchell Geisler | President, CEO & Director | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.